Stocks Comparison
Becton Dickinson vs Boston Scientific: revenue, profit, margins and growth compared
Becton Dickinson brought in $21.8B of revenue in fiscal 2025, Boston Scientific $20.1B in fiscal 2025. Revenue changed by +8.2% at Becton Dickinson and +19.9% at Boston Scientific on the year before, so Boston Scientific grew faster. Becton Dickinson kept 7.7% of its revenue as net profit, Boston Scientific 14.4%. Free cash flow was $2.7B at Becton Dickinson and $3.7B at Boston Scientific.
Side by side, latest fiscal year
| BDX | BSX | |
|---|---|---|
| Fiscal year ended | FY2025 (September 30, 2025) | FY2025 (December 31, 2025) |
| Revenue | $21.8B | $20.1B |
| Revenue growth | +8.2% | +19.9% |
| Net income | $1.7B | $2.9B |
| Net margin | 7.7% | 14.4% |
| Free cash flow | $2.7B | $3.7B |
| Free cash flow margin | 12.2% | 18.2% |
| Earnings per share (diluted) | $5.82 | $1.94 |
| Cash | $567M | $2B |
| Debt | $17.6B | $11.1B |
| Price to earnings | 31.6 | 22.6 |
| Market value | $50.1B | $63.7B |
| Dividend yield | 2.26% | n/a |
| Rank by revenue in sector | #27 of 523 · Health care | #30 of 523 · Health care |
Over the years
Questions about Becton Dickinson and Boston Scientific
Which is bigger by revenue, Becton Dickinson or Boston Scientific?
Becton Dickinson is bigger by revenue: $21.8B in fiscal 2025, against $20.1B for Boston Scientific in fiscal 2025.
Which keeps more of its revenue as profit, Becton Dickinson or Boston Scientific?
Becton Dickinson had a net margin of 7.7% in fiscal 2025; Boston Scientific had 14.4% in fiscal 2025.
Which grew revenue faster, Becton Dickinson or Boston Scientific?
In their latest fiscal years revenue changed by +8.2% at Becton Dickinson and +19.9% at Boston Scientific.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.